Effectiveness of entecavir treatment and predictive factors for virologic response

Effectiveness of entecavir treatment and predictive factors for virologic response

Introduction: Entecavir (ETV) is a potent inhibitor of hepatitis B virus (HBV) replication. In patients adherent to treatment, virologic remission rates of > 95 % can be maintained with entecavir at 3-5 years Aim and methods: A cohort study was performed, including all subjects who received ETV f...

Full description

Bibliographic Details
Main Authors: Carmen Monica Preda, Cristian Baicus, Lucian Negreanu, Letitia Tugui, Sandra Viviana Olariu, Adriana Andrei, Ileana Zambatu, Mircea Mihai Diculescu
Format: Article
Language:English
Published: Aran Ediciones 2014-05-01
Series:Revista Espanola de Enfermedades Digestivas
Subjects:
Chronic hepatitis B
HBe antigen positive
Hbe antigen negative
Entecavir
Online Access:http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082014000500002&lng=en&tlng=en

Internet

http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-01082014000500002&lng=en&tlng=en

Similar Items